Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

ClinicalTrials.gov ID: NCT04677569

Public ClinicalTrials.gov record NCT04677569. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 10:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this study is to evaluate the efficacy of ALIS (amikacin liposome inhalation suspension) + background regimen (azithromycin \[AZI\] + ethambutol \[ETH\]) compared to the ELC (empty liposome control) + background regimen on participant-reported respiratory symptoms at Month 13.

Study identification

NCT ID
NCT04677569
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Insmed Incorporated
Industry
Enrollment
425 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2021 (Actual)
Primary completion
Nov 21, 2025 (Actual)
Completion
Jan 15, 2026 (Actual)
Last update posted
Feb 3, 2026

2021 – 2026

United States locations

U.S. sites
90
U.S. states
28
U.S. cities
74
Facility City State ZIP Site status
USA008 Birmingham Alabama 35233-1711 —
USA062 Fresno California 93701 —
USA060 Los Angeles California 90033-5313 —
USA090 Newport Beach California 92663 —
USA058 Sacramento California 95817 —
USA048 San Diego California 92103 —
USA081 San Francisco California 94143 —
USA055 Santa Barbara California 93105 —
USA050 Stanford California 94305 —
USA001 Denver Colorado 80206 —
USA023 Washington D.C. District of Columbia 20007 —
USA080 Bradenton Florida 34209 —
USA028 Brandon Florida 33511-5719 —
USA003 Clearwater Florida 33765 —
USA043 Jacksonville Florida 32204 —
USA072 Jacksonville Florida 32207-8567 —
USA085 Jacksonville Florida 32209-6511 —
USA047 Jacksonville Florida 32224 —
USA042 Kissimmee Florida 34746 —
USA019 Leesburg Florida 34748 —
USA039 Naples Florida 34102-5444 —
USA096 Naples Florida 34102 —
USA097 Naples Florida 34102 —
USA046 New Port Richey Florida 34652 —
USA054 Sarasota Florida 34239-2913 —
USA084 Sebastian Florida 32958 —
USA026 Sebring Florida 33870 —
USA070 St. Petersburg Florida 33704-2733 —
USA014 St. Petersburg Florida 33707 —
USA067 Tampa Florida 33606 —
USA068 Tampa Florida 33614-7101 —
USA053 Weston Florida 33331 —
USA038 Atlanta Georgia 30342-2147 —
USA066 Augusta Georgia 30912 —
USA004 Lawrenceville Georgia 30046-3325 —
USA029 Rincon Georgia 31326 —
USA079 Coeur d'Alene Idaho 83814 —
USA031 Chicago Illinois 60611 —
USA073 Springfield Illinois 62702-4968 —
USA030 Springfield Illinois 62702 —
USA074 Iowa City Iowa 52242-1081 —
USA037 Kansas City Kansas 66160 —
USA002 New Orleans Louisiana 70112 —
USA017 Baltimore Maryland 21224-3057 —
USA099 Lexington Massachusetts 02421 —
USA077 Springfield Massachusetts 01107 —
USA013 Rochester Minnesota 55905 —
USA082 Columbia Missouri 65212-1000 —
USA061 St Louis Missouri 63110 —
USA045 Omaha Nebraska 68124 —
USA009 Omaha Nebraska 68198 —
USA069 Hillsborough New Jersey 08844 —
USA032 Toms River New Jersey 08755-8000 —
USA065 Bayside New York 11361 —
USA088 East Syracuse New York 13057 —
USA011 New York New York 10017 —
USA059 The Bronx New York 10461 —
USA076 Charlotte North Carolina 28204 —
USA035 Charlotte North Carolina 28273 —
USA033 Charlotte North Carolina 28277-8915 —
USA051 Durham North Carolina 27710-0001 —
USA034 Mooresville North Carolina 28117 —
USA007 Winston-Salem North Carolina 27103 —
USA075 Cincinnati Ohio 45242-4402 —
USA064 Cincinnati Ohio 45267 —
USA018 Cleveland Ohio 44195 —
USA063 Columbus Ohio 43210-1240 —
USA071 Portland Oregon 97213-2982 —
USA025 Portland Oregon 97239 —
USA015 DuBois Pennsylvania 15801 —
USA040 Philadelphia Pennsylvania 19104 —
USA093 Philadelphia Pennsylvania 19107 —
USA092 Providence Rhode Island 02906 —
USA044 Anderson South Carolina 29621 —
USA024 Charleston South Carolina 29414 —
USA020 Charleston South Carolina 29425 —
USA012 Rock Hill South Carolina 29732 —
USA022 Franklin Tennessee 37067 —
USA041 Hendersonville Tennessee 37075 —
USA078 Nashville Tennessee 37232 —
USA016 Dallas Texas 75246 —
USA100 Dallas Texas 75246 —
USA091 Denison Texas 75020 —
USA086 Houston Texas 77070-1190 —
USA021 McKinney Texas 75069-8085 —
USA006 San Antonio Texas 78258 —
USA089 Temple Texas 76508 —
USA052 Tyler Texas 75708 —
USA083 Charlottesville Virginia 22903 —
USA087 Madison Wisconsin 53792-0001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 168 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04677569, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04677569 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →